Echo Therapeutics, Inc. Deferred Tax Assets, Valuation Allowance
Echo Therapeutics, Inc. had Deferred Tax Assets, Valuation Allowance of -$42.53 million as of 2015-12-31, per its 10-K filed 2016-03-30.
Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Assets, Net of Valuation Allowance
us-gaap:DeferredTaxAssetsValuationAllowance · last filed 2016-03-30
- 2015-12-31: Deferred Tax Assets, Valuation Allowance -$42.53M.
- 2014-12-31: Deferred Tax Assets, Valuation Allowance -$42.53M; Deferred Tax Assets, Valuation Allowance as first filed -$34.63M.
- 2013-12-31: Deferred Tax Assets, Valuation Allowance -$34.63M; Deferred Tax Assets, Valuation Allowance as first filed -$32.86M.
- 2012-12-31: Deferred Tax Assets, Valuation Allowance -$22.63M.
| Period end | Deferred Tax Assets, Valuation Allowance | Deferred Tax Assets, Valuation Allowance as first filed |
|---|---|---|
| 2015-12-31 | -$42.53M 10-K · filed 2016-03-30 | |
| 2014-12-31 | -$42.53M 10-K · filed 2016-03-30 | -$34.63M 10-K · filed 2015-04-15 |
| 2013-12-31 | -$34.63M 10-K · filed 2015-04-15 | -$32.86M 10-K · filed 2014-03-28 |
| 2012-12-31 | -$22.63M 10-K · filed 2014-03-28 | |
| 2011-12-31 | -$17.63M 10-K · filed 2013-03-18 |